HOME >> MEDICINE >> NEWS
News briefs from the Journal CHEST, December 2004

ASTHMATICS WITH FREQUENT MENTAL DISTRESS HAVE UNHEALTHY BEHAVIORS

Asthmatics with frequent mental distress (FMD) are significantly more likely to engage in behaviors that may cause asthma flare-ups and endanger their health than asthmatics without FMD, according to a new study by researchers at the Centers for Disease Control and Prevention (CDC), in Atlanta, GA. Researchers surveyed 15,080 asthmatics and found that those with FMD, classified as 14 or more days a month of mental health that was not good, were more likely to be current smokers, to be physically inactive, and to be obese than other asthmatics. Survey results also showed that 18.8% of asthmatics were found to suffer from FMD, more than double the 9.3% of nonasthmatics with FMD. Those with asthma and FMD were significantly more likely to report fair or poor general health, frequent physical distress, frequent activity limitations, frequent anxiety, and frequent sleeplessness. The study appears in the December issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians.

MODEL ACCURATELY PREDICTS LUNG CANCER MORTALITY RATES IN SMOKERS

A new statistical model predicts lung cancer mortality rates in smokers and former smokers, without prior screening. Utilizing data from the Carotene and Reinol Efficacy Trial (CARET), researchers from New York, NY, Milan, Italy, and Lyon, France, developed a formula to predict lung cancer mortality in 8,825 subjects, based on each subject's risk factors for lung cancer mortality, such as age and smoking history. To verify the model's accuracy, researchers tested the model on three study cohorts, separately and combined. When combined, the model predicted 308 deaths due to lung cancer, and 319 deaths were actually observed. This model would essentially allow study subjects to serve as their own control group, because researchers would be able to compare the actual lung cancer mortality rates of subj
'"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
13-Dec-2004


Page: 1 2

Related medicine news :

1. News briefs from the journal CHEST, March 2005
2. LA BioMed medical/research briefs March 2005
3. News briefs from the journal CHEST, February 2005
4. LA BioMed medical/research briefs January 2005
5. News briefs from the journal Chest, January 2005
6. LA BioMed Medical/Research briefs January 2005
7. News briefs from the Journal CHEST, November 2004
8. LA BioMed research briefs
9. News briefs from the journal Chest, October 2004
10. News briefs from the journal Chest, June 2004
11. News briefs from the journal CHEST, May 2004

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: News briefs from the Journal CHEST December

(Date:4/24/2014)... from The University of Manchester have identified a way ... more open to treatment. , The study published today ... for the development of drugs to target cells that ... made the discovery whilst exploring the possible mechanisms behind ... treat breast and colon cancer. , Dr Andrew Gilmore, ...
(Date:4/24/2014)... with an antimicrobial peptide could help to lower the risk ... Optometry and Vision Science , official journal of the ... published by Lippincott Williams & Wilkins , a part ... and now humans support the biocompatibility and safety of lenses ... research by Debarun Dutta, B.Optom, of The University of New ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: